qPCR was performed for the treated murine 4T1, LLC, and CT26 cancer cell lines, and the data showed that the total expression levels of CCL5, CXCL9, and CXCL10 were significantly increased after tucidinostat treatment (Fig. 2c). This evidence concerns the gene CXCL9 and cancer.